Leukemia Research
Volume 33, Issue 12 , Pages 1581-1583, December 2009

How do JAK2-inhibitors work in myelofibrosis: An alternative hypothesis

  • Alessandro M. Vannucchi

      Affiliations

    • Corresponding Author InformationCorrespondence address: Department of Hematology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy. Tel.: +39 055 7947 688; fax: +39 055 7947 688.

UF of Hematology, Department of Critical care, University of Florence, Florence, Italy

Received 3 June 2009; received in revised form 3 June 2009; accepted 3 June 2009. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(09)00281-1

doi:10.1016/j.leukres.2009.06.001

Leukemia Research
Volume 33, Issue 12 , Pages 1581-1583, December 2009

Article Tools

* Image Usage & Resolution